NYSE$HNGE
Hinge Health Inc · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
HNGE reported Q1 2026 revenue of $182.3M and net income of $35.1M, with diluted EPS of $0.41.
For Q1 2026, HNGE reported revenue of $182.3M and net income of $35.1M. Management discusses segment performance, costs, and liquidity in the quarterly filing.
- Revenue of $182.3M for Q1 2026.
- Net income of $35.1M; diluted EPS $0.41.
- Operating trends and segment mix are detailed in the quarterly report.
- Liquidity, capital allocation, and macro exposure are discussed in MD&A.
Headline financials
Revenue & EPS history
Hinge Health, Inc. · Revenue · Quarterly
$182M
Forward guidance
The 10-Q does not provide numeric consolidated annual EPS guidance for HNGE. Management commentary in MD&A covers costs, capital, and sector-specific risks.
Tailwinds
- Management discusses operational priorities and liquidity in the quarterly filing.
- Segment or product trends are disclosed where applicable to the business model.
Headwinds
- Macro, input-cost, and interest-rate exposure can affect near-term results.
- One-time items, impairments, or fair-value marks may distort quarterly comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports · overlaid with Q1 2026
+7.3%
Avg return
Earnings day
+9.1%
Avg return
5 days after
+15.0%
Avg return
30 days after
75%
3 / 4 earnings
Positive
+17.3%
Q4 2025
Best reaction
-1.6%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.4% | +15.3% | +29.3% | |
| Q4 2025 | +17.3% | +17.8% | +36.2% | |
| Q3 2025 | -1.6% | +2.8% | -2.5% | |
| Q2 2025 | +11.3% | +0.3% | -3.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro